HCA (HCA) Cowen Maintains Buy, PT Raised to $561 March 2026

Cowen & Co. maintained a Buy on HCA Healthcare, Inc. (HCA) and raised its price target to $561 on March 10, 2026. The HCA analyst rating was recorded at 09:09 AM ET and shows a modest near-term market reaction, with the stock moving 0.23% ($1.25) on the update. This notice summarizes the rating action, the new HCA price target, the market context, and what investors should watch next.